Impact of AdipoR1 expression on breast cancer development (Q38418288)

2 September 2017

title

Impact of AdipoR1 expression on breast cancer development (English)

1 reference

2 September 2017

7

Christian F Singer

1 reference

2 September 2017

Georg Pfeiler

1

1 reference

2 September 2017

Gernot Hudelist

2

1 reference

2 September 2017

Pia Wülfing

3

1 reference

2 September 2017

Bjoern Mattsson

4

1 reference

2 September 2017

Robert Königsberg

5

1 reference

2 September 2017

Ernst Kubista

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

13 January 2010

1 reference

2 September 2017

1 reference

2 September 2017

volume

117

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

134-138

1 reference

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Adiponectin and breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

AMPK, the metabolic syndrome and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Serum adiponectin and leptin levels in Taiwanese breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Effects of adiponectin on breast cancer cell growth and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

Plasma adiponectin concentrations and risk of incident breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.018

10.1016/J.YGYNO.2009.12.018

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference